Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study | |
Li, Q.; Li, H.; Jiang, H.; Feng, Y.; Cui, Y.; Wang, Y.; Ji, Y.; Yu, Y.; Li, W.; Xu, C. | |
刊名 | CLINICAL & TRANSLATIONAL ONCOLOGY |
2018 | |
卷号 | 20期号:6 |
关键词 | Gastric cancer HER2 Trastuzumab Predictive factors |
ISSN号 | 1699-048X |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3605283 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Li, Q.,Li, H.,Jiang, H.,et al. Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study[J]. CLINICAL & TRANSLATIONAL ONCOLOGY,2018,20(6). |
APA | Li, Q..,Li, H..,Jiang, H..,Feng, Y..,Cui, Y..,...&Liu, T..(2018).Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study.CLINICAL & TRANSLATIONAL ONCOLOGY,20(6). |
MLA | Li, Q.,et al."Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study".CLINICAL & TRANSLATIONAL ONCOLOGY 20.6(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论